Biomerica Inc (BMRA) Stock Price Gains While Sentiment Increases

May 28, 2018 - By Nellie Frank

Biomerica, Inc. (NASDAQ:BMRA) Logo

Sentiment for Biomerica Inc (BMRA)

Biomerica Inc (BMRA) institutional sentiment increased to 1 in 2017 Q4. Its up 0.75, from 0.25 in 2017Q3. The ratio has improved, as 4 institutional investors increased and started new stock positions, while 4 sold and reduced stakes in Biomerica Inc. The institutional investors in our partner’s database now own: 109,831 shares, up from 66,682 shares in 2017Q3. Also, the number of institutional investors holding Biomerica Inc in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 2 Increased: 0 New Position: 4.

Biomerica, Inc., together with its subsidiaries, develops, makes, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions worldwide. The company has market cap of $33.22 million. The companyÂ’s diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications; and to measure the level of specific hormones, antibodies, antigens, or other substances, which exist in the human body in extremely small concentrations. It currently has negative earnings. It primarily focuses on products for gastrointestinal, food intolerances, diabetes, and esoteric tests.

The stock increased 2.40% or $0.09 during the last trading session, reaching $3.84. About 14,180 shares traded. Biomerica, Inc. (BMRA) has risen 113.88% since May 28, 2017 and is uptrending. It has outperformed by 102.33% the S&P500.

Analysts await Biomerica, Inc. (NASDAQ:BMRA) to report earnings on August, 29. They expect $-0.06 EPS, down 50.00 % or $0.02 from last year’s $-0.04 per share. After $-0.04 actual EPS reported by Biomerica, Inc. for the previous quarter, Wall Street now forecasts 50.00 % negative EPS growth.

Bank Of America Corp De holds 0% of its portfolio in Biomerica, Inc. for 3,832 shares. Deutsche Bank Ag owns 2,200 shares or 0% of their US portfolio. Moreover, Millennium Management Llc has 0% invested in the company for 11,167 shares. The New York-based Morgan Stanley has invested 0% in the stock. Panagora Asset Management Inc, a Massachusetts-based fund reported 6,347 shares.

Since January 1, 0001, it had 4 insider purchases, and 0 insider sales for $65,333 activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.